Lucid EV / EBITDA
Was ist das EV / EBITDA von Lucid?
EV / EBITDA von Lucid, Inc. ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Lucid
Was macht Lucid?
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Unternehmen mit ev / ebitda ähnlich Lucid
- Pure Alumina hat EV / EBITDA von N/A
- Bounty Mining hat EV / EBITDA von N/A
- Calyx Ventures hat EV / EBITDA von N/A
- Neuropathix hat EV / EBITDA von N/A
- Xinhua News Media hat EV / EBITDA von N/A
- Creo Medical Plc hat EV / EBITDA von N/A
- Lucid hat EV / EBITDA von N/A
- Precipitate Gold hat EV / EBITDA von N/A
- Strong Petrochemical hat EV / EBITDA von N/A
- ParcelPal Technology hat EV / EBITDA von N/A
- Tasman Resources Ltd hat EV / EBITDA von N/A
- Bankers Cobalt hat EV / EBITDA von N/A
- Reitmans (Canada) hat EV / EBITDA von N/A